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A B S T R A C T
Background
Leg ulceration is a common, chronic, recurring condition. The estimated prevalence of leg ulcers in the UK population is 1.5 to 3 per
1000. Venous ulcers (also called stasis or varicose ulcers) comprise 80% to 85% of all leg ulcers. Electromagnetic therapy (EMT) is
sometimes used as a treatment to assist the healing of chronic wounds such as venous leg ulcers.
Objectives
To assess the effects of EMT on the healing of venous leg ulcers.
Search methods
For this third update, we searched The Cochrane Wounds Group Specialised Register (searched 12 November 2012); The Cochrane
Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 10); Ovid MEDLINE (2011 to NovemberWeek
1 2012); Ovid MEDLINE (In-Process & Other Non-Indexed Citations, November 12, 2012); Ovid EMBASE (2011 to 2012 Week
45); and EBSCO CINAHL (2011 to 9 November 2012).
Selection criteria
Randomised controlled trials comparing EMT with sham-EMT or other treatments.
Data collection and analysis
At least two review authors independently scrutinised search results and obtained full reports of potentially eligible studies for further
assessment. We extracted and summarised details of eligible studies using a data extraction sheet, and made attempts to obtain missing
data by contacting study authors. A second review author checked data extraction, and we resolved disagreements after discussion
between review authors.
Main results
Three randomised controlled trials (RCTs) of variable quality involving 94 people were included in the original review; subsequent
updates have identified no new trials. All the trials compared the use of EMT with sham-EMT. In the two trials that reported healing
rates; one small trial (44 participants) reported that significantly more ulcers healed in the EMT group than the sham-EMT group
however this result was not robust to different assumptions about the outcomes of participants who were lost to follow up. The second
trial that reported numbers of ulcers healed found no significant difference in healing. The third trial was also small (31 participants)
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and reported significantly greater reductions in ulcer size in the EMT group however this result may have been influenced by differences
in the prognostic profiles of the treatment groups.
Authors’ conclusions
There is no high quality evidence that electromagnetic therapy increases the rate of healing of venous leg ulcers, and further research is
needed.
P L A I N L A N G U A G E S U M M A R Y
Electromagnetic therapy (EMT) for treating venous leg ulcers
Venous leg ulcers (which appear as open sores) can be caused by a blockage or breakdown in the veins of the legs. Compression of
the leg, using bandages or hosiery (stockings), can help heal most of these ulcers. Electromagnetic therapy is also sometimes offered.
Electromagnetic therapy is not a form of radiation or heat, but uses an electromagnetic field to try to promote healing. This review of
clinical trials concluded that there is no high quality evidence that electromagnetic therapy speeds the healing of venous leg ulcers.
B A C K G R O U N D
Description of the condition
A leg ulcer is a common, chronic, recurring condition defined as
the “loss of skin below the knee on the leg or foot, which takes
more than six weeks to heal” (NHS CRD 1997). The estimated
prevalence of leg ulcers within the UK population is 1.5 to 3 per
1000; however, prevalence increases with age, mounting to 20 per
1000 in people over 80 years old (NHSCRD 1997), and is higher
amongst women (Callam 1986). Callam 1986 reported that 45%
of people with leg ulcers in a Scottish study experienced episodes
of ulceration for more than 10 years. Leg ulcers constitute a con-
siderable cost to both the patient (Charles 1995) and the health
service (Bosanquet 1992). Indeed, the economic cost of leg ulcers
to the National Health Service (NHS) in the UK has been esti-
mated at £400 million a year (Simon 2004). Venous ulcers (also
known as stasis or varicose ulcers) constitute 80% to 85% of all
leg ulcers (Simon 2004). These are caused by venous insufficiency
which has been shown to be associated with increased hydrostatic
pressure in the veins of the leg. The application of external com-
pression reverses this and generally leads to the healing of the ul-
cers (O’Meara 2012). However, a significant proportion of ulcers
do not heal with compression therapy and additional treatments
are used for this group of people.
Description of the intervention
Recently, there has been an increasing interest in the therapeutic
use of electromagnetic fields for various medical conditions, in-
cluding venous leg ulcers (Markov 2007). Electromagnetic therapy
(EMT), also known as electromagnetism, bioelectricity, magneto
biology, magnetic healing and magnetic field therapy, uses elec-
tromagnetic energy applied to the body to treat various medical
conditions, from bone and cartilage repair (Haddad 2007; Ryaby
1998) to pain relief (Shupak 2006; Thomas 2007), wound heal-
ing (Kenkre 1996; Stiller 1992), and relatively new applications
such as chronic musculoskeletal pain (Thomas 2007). EMT does
not use direct electrical effects or radiation, unlike other forms of
electrotherapy, but induces a field effect (Stiller 1992). A number
of devices have been constructed to deliver either a continuous
or a pulsed electromagnetic field (PEMF). PEMFs are produced
with an ’on-off ’ effect of pulsing current to produce field effects,
which, it has been suggested, may influence tissue generation and
cell proliferation, and thus may be useful for wound healing. The
main advantage of PEMF compared with continuous fields is that
the short duration of the pulses protects the tissues against poten-
tial damage from heat generated by continuous fields (Athanasiou
2007).
How the intervention might work
There are several theories that explain how the PEMF may exert
its effect on tissue generation and cell proliferation in wound heal-
ing. Lee 1993 suggested that PEMFmight facilitate the migration
of electrically-charged cells involved in repairing the wound area,
thereby restoring the metabolic conditions of the healing cells. It
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has also been proposed that PEMF induces a tiny electrical signal
on the injured cell membrane, which initiates a series of physiolog-
ical effects that include an increase in the number of macrophages
and fibroblasts present in the wound, a reduction of the inflam-
mation, and an increased deposition of collagen and fibrin, all of
which contribute to the healing process (Markoll 2003). Other
theories suggest that PEMF is associated with the production of
free radicals within cells, which mediate intracellular communica-
tion (Gordon 2007). PEMFmay exert several biological processes
involved in wound healing but the exact mechanism is not clear.
Why it is important to do this review
The lack of response to standard therapies for chronic leg ulcers
gives impetus to this review.There are also several anecdotal reports
of the beneficial effects of EMT for chronic skin wounds, despite
the lack of standardisation of the PEMF devices in terms of type,
duration, frequency, intensity and length of exposure. A systematic
review to assess the available evidence for EMT on venous leg
ulcers is therefore merited.
O B J E C T I V E S
To assess the evidence for the effects of EMT on the healing of
venous leg ulcers.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs). There was no restriction on
the basis of language, date of trial publication or publication status.
Types of participants
Studies that involved people of any age, and in any care setting,
described as having a venous leg ulcer were eligible for inclusion.
As the method of diagnosis of venous ulceration differed between
the trials, and was not always described, it was not possible to
apply a standard definition for diagnosis of venous ulcers.
Types of interventions
Any form of electromagnetic therapy (EMT) for healing of venous
ulcers compared with sham-EMT, no EMT or other treatments.
Types of outcome measures
Primary outcomes
• Proportion of ulcers healed within trial period
• Rate of change in ulcer area
• Time to complete healing
Secondary outcomes
• Costs
• Quality of life
• Pain
• Acceptability of treatment
• Adverse effects
Search methods for identification of studies
Electronic searches
The search methods section for the second update of this review
can be found in Appendix 1. For this third update, we searched
the following electronic databases:
• The Cochrane Wounds Group Specialised Register
(searched 12 November 2012);
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2012, Issue 10);
• Ovid MEDLINE (2011 to November Week 1 2012);
• Ovid MEDLINE (In-Process & Other Non-Indexed
Citations, November 12, 2012);
• Ovid EMBASE (2011 to 2012 Week 45);
• EBSCO CINAHL (2011 to 9 November 2012).
We used the following search strategy in the Cochrane Central
Register of Controlled Trials (CENTRAL):
#1MeSHdescriptor Electromagnetic Phenomena explode all trees
#2 MeSH descriptor Electric Stimulation Therapy explode all
trees
#3 (electromagnetic* or electrotherap*):ti,ab,kw
#4 (electric* NEXT current):ti,ab,kw
#5 ((direct or pulsed or alternating) NEXT current):ti,ab,kw
#6 (low NEXT intensity) or (low NEXT frequency):ti,ab,kw
#7 (high NEXT voltage):ti,ab,kw
#8 (“TENS” or “NMES”):ti,ab,kw
#9 (interferential NEXT therap*):ti,ab,kw
#10 (monophasic or galvanic):ti,ab,kw
#11 MeSH descriptor Diathermy explode all trees
#12 MeSH descriptor Microwaves explode all trees
#13 (diatherm* or microwave*):ti,ab,kw
#14 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR
#9 OR #10 OR #11 OR #12 OR #13)
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#15 MeSH descriptor Leg Ulcer explode all trees
#16 (varicose NEXT ulcer*) or (venous NEXT ulcer*) or (leg
NEXT ulcer*) or (foot NEXT ulcer*) or (stasis NEXT ulcer*)
or ((lower NEXT extremit*) NEAR/2 ulcer*) or (crural NEXT
ulcer*) or “ulcus cruris”:ti,ab,kw
#17 (#15 OR #16)
#18 (#14 AND #17)
The search strategies for Ovid MEDLINE, Ovid EMBASE and
EBSCO CINAHL can be found in Appendix 2, Appendix 3 and
Appendix 4, respectively. We combined the Ovid MEDLINE
search with the Cochrane Highly Sensitive Search Strategy for
identifying randomised trials in MEDLINE: sensitivity- and pre-
cision-maximising version (2008 revision) (Lefebvre 2011). We
combined the Ovid EMBASE and EBSCO CINAHL searches
with the trial filters developed by the Scottish Intercollegiate
Guidelines Network (SIGN 2009). There were no restrictions on
the basis of date or language of publication.
Searching other resources
For the second update, we checked the bibliography of the sys-
tematic review by McGaughey 2009.
Data collection and analysis
Selection of studies
At least two review authors independently scrutinised the search
results. We obtained full reports of articles if, from the initial as-
sessment, they appeared to satisfy the inclusion criteria. We re-
solved disagreements by discussion between review authors.
Data extraction and management
We included data from studies published in duplicate only once.
We extracted and summarised details of eligible studies using a
data extraction sheet and made attempts to obtain missing data
by contacting authors. A second review author checked data ex-
traction. We extracted the following data:
• design of study;
• inclusion and exclusion criteria;
• baseline characteristics (by treatment group);
• intervention details;
• outcome measures used;
• results (by treatment group);
• withdrawals (by treatment group); and
• adverse effects.
Assessment of risk of bias in included studies
For this review two review authors independently assessed each
included study using the Cochrane Collaboration tool for assess-
ing risk of bias (Higgins 2011). This tool addresses six specific
domains, namely sequence generation, allocation concealment,
blinding, incomplete outcome data, selective outcome reporting
and other issues (e.g. extreme baseline imbalance) (see Appendix
5 for details of the criteria on which the judgement was based).
We assessed blinding and completeness of outcome data for each
outcome separately. We completed a ’Risk of bias’ table for each
eligible study and discussed any disagreement amongst all review
authors to achieve a consensus.
We explicitly judged each of these criteria using the following
system: ’Yes’ (i.e. low risk of bias); ’No’ (i.e. high risk of bias); and
’Unclear’ (i.e. either lack of information or uncertainty over the
potential for bias). We presented an assessment of risk of bias using
a ’Risk of bias’ summary figure, which shows all the judgements
in a cross-tabulation of study by entry (Figure 1; Figure 2).
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Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Data synthesis
Wepresented all results quantitatively where possible, and in a nar-
rative summary where there were insufficient data. For each trial
with dichotomous outcomes (e.g. were ulcers healed? (yes or no)),
we calculated a risk ratio (RR) of healing with 95% confidence in-
tervals. Where outcomes for continuous variables were presented
without confidence intervals, standard deviations, or some mea-
sure of the precision of the result, we entered the data into the
Characteristics of included studies and did not use them in data
pooling.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
For the third update of the review we identified no new studies
that met the inclusion criteria.
Included studies
We included three studies of EMT in the review (Ieran 1990;
Kenkre 1996; Stiller 1992). All studies compared the use of EMT
with sham-EMT. They were small, with sample sizes ranging from
19 to 44. All participants were considered to have venous leg ul-
cers, although none of the studies reported how assessments were
conducted.
Ieran 1990 recruited 44 people with venous leg ulcers to a double-
blind RCT conducted in Italy. Participants were randomised to
receive either EMT (75 Hz, 2.7 mT, with an impulse width 1.3
ms; n = 22) for four hours per day or sham stimulation for the same
period of time (n = 22). Patients carried out the stimulation at
home. No compression therapy was administered. Oral and local
antibiotic therapy was given concomitantly to both groups. The
study ran for a three-month period. The outcome measured was
the percentage of ulcers healed and the size of wound area at three
months.
Kenkre 1996 examined the treatment of venous leg ulcers with
EMT in a randomised, controlled, double-blind trial based in a
leg ulcer clinic in an urban general practice in Birmingham, UK.
Nineteen people were randomly allocated into three arms: the first
treatment group received 600 Hz electric field, and 25 mT mag-
netic field, delivered by an Elmedistraal device (which generates
perpendicular electric and magnetic fields). The second group re-
ceived 600 Hz on days one to five, and 800 Hz on days six to 30
from a 25 mTmagnetic field, delivered by an Elmedistraal device,
for 30 minutes, five days a week for a total of 30 days followed by
four weeks’ observation. The control group received sham therapy.
All participants had ulcer dressings changed by community staff,
although there was no standardisation of dressings. All patients
were reported to be receiving compression therapy; the authors
reported that only two people received “adequate” compression.
The primary outcome was the percentage of ulcers healed and
changes in the ulcer area at day 50. Healing was based on clinical
assessment scores which assessed changes in wound area.
Stiller 1992 randomised 31 people into a multi-centre, double-
blind, sham-controlled trial in the USA. Eighteen people ran-
domised to the active treatment group received the following:
pulsed EMT (0.06 mV/cm, with a signal which was a three-part
pulse [+, -, +] of 3.5ms total width and a duty cycle of 25%), deliv-
ered by a Pulsed Electromagnetic Limb Ulcer Therapy (PELUT)
device for three hours a day, plus standard treatment (ancillary
topical treatment). Thirteen people were randomised to receive
sham-EMT and standard treatment. The groups were treated over
an eight-week period, or until the ulcer healed, whichever came
first. Treatment continued for 12 weeks for patients who showed a
favourable response at eight weeks. Standard treatment consisted
of compression bandaging, leg elevation and the use of one of five
named dressings. The outcomes measured were percentage change
in wound area, mean decrease in wound depth, percentage change
in area of granulation tissue, and percentage of ulcers healed or
markedly improved at week eight. Wound healing was based on
the investigators’ clinical global assessment of the healing status
which considered wound area, ulcer depth, appearance of granu-
lation and pain. The percentage of ulcers either healed or showing
marked improvement was combined and not presented separately
in the study report.
Excluded studies
We added two studies, both CCTs, to the table Excluded studies
(Jeran 1987; Todd 1991).
Risk of bias in included studies
Risk of bias in the included studies is summarised in Figure 1 and
Figure 2.
Allocation
For sequence generation, two trials clearly reported adequate ran-
domisation (Ieran 1990; Stiller 1992), in that participants were
randomly distributed to the control or experimental group accord-
ing to a computer-generated code. While we judged risk of bias
due to allocation concealment to be low for Ieran 1990, it was not
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clear whether allocation was concealed for Stiller 1992. Kenkre
1996 described their study as randomised, however, the methods
of sequence generation, as well as allocation concealment, were
unclear.
Blinding
All trials were reported as “double-blind.” Ieran 1990 and Stiller
1992 described in detail how the active and dummy devices were
indistinguishable to patients and investigators; in Kenkre 1996
there was insufficient information on how the participants and
outcome assessors were blinded.
Incomplete outcome data
In judging the risk of bias for incomplete outcome reporting, we
considered all primary outcome measures; namely, the proportion
of wounds healed, and the reduction in wound size and time to
complete healing. We also considered whether an intention-to-
treat (ITT) analysis was reported for the primary outcomes and
whether missing data were imputed appropriately.
We considered risk of bias due to incomplete outcome data low
in Kenkre 1996 and Stiller 1992. No participants were excluded
or lost to follow up in Kenkre 1996, while Stiller 1992 imputed
missing data based on the last observed values carried forward and
made an estimation by linear extrapolation for the wound size
outcome; the imputation results based on these two methods were
reported to be in agreement with one another. Ieran 1990 did not
conduct an ITT analysis and missing outcome data were slightly
more in the EMT group (4/22; 18%) compared to the sham-EMT
group (3/22; 14%); risk of bias due to this slight imbalance was
thus unclear.
Selective reporting
In judging the risk of bias for selective reporting, we were unable
to assess the trial protocols and therefore assessed the studies based
on the pre-specified outcome measures reported in the methods
section of the trial report. The risk of bias due to selective reporting
was considered low for all three trials as all of the pre-specified
outcomes were reported.
Other potential sources of bias
Two trials were partly sponsored by themanufacturer of the device
(Kenkre 1996; Stiller 1992). There is evidence that industry-spon-
sored trials may overestimate the treatment effect (see Bhandari
2004).
Effects of interventions
Electromagnetic therapy (EMT) compared with sham
therapy
Primary outcomes
Number of wounds healed
We did not pool data from Ieran 1990 and Kenkre 1996 because
these trials had different treatment durations. Stiller 1992 did not
assess this outcome.
Number of wounds healed at 90 days
Ieran 1990 reported that three people in the sham-EMT group
(3/22, 14%) and four in the EMT group (4/22, 18%) were lost
to follow up. Therefore, 19 people in the sham group and 18
in the EMT group were included in the complete case analysis.
Assessment at 90 days found that 12/18 (67%) ulcers had healed in
the EMTgroup comparedwith 6/19 (32%) in the shamgroup (RR
2.11; 95%CI 1.01 to 4.42) (Analysis 1.1). The difference between
the groupswasmarginally statistically significant in favour of EMT
(P = 0.05), however, this is a small study which did not conduct
an intention-to-treat (ITT) analysis and had missing data in each
arm.This studywas at low tomoderate risk of bias overall as aspects
of bias, namely sequence generation, allocation concealment and
blinding, were adequately achieved.
To assess the potential impact of loss to follow up on effect esti-
mates in Ieran 1990, we considered two assumptions; the worst-
case scenario and the best-case scenario. In the worst-case scenario
all the people lost to follow up were regarded as treatment failures
(wounds not healed), and in the best-case scenario all the losses to
follow up were considered as treatment successes (wounds healed).
The significance of the results changed with the two assumptions
made. In theworst-case scenario, the difference between the groups
was found to be not statistically significant (RR 2.00; 95%CI 0.92
to 4.37) (Analysis 2.1) while in the best-case scenario assumption
the difference between the groups was shown to be statistically
significant (RR 1.78; 95% CI 1.01 to 3.12) (Analysis 3.1).
Number of wounds healed at 50 days
In Kenkre 1996 there was no loss to follow up. We grouped the
two EMT treatment arms together. At day 50, 2/10 (20%) venous
ulcers were healed in the EMT group compared with 2/9 (22%)
in the sham-EMT group (RR 0.90; 95% CI 0.16 to 5.13). The
difference between the groups was not statistically significant (
Analysis 4.1). This study was at unclear risk of bias as aspects
8Electromagnetic therapy for treating venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
of bias, namely sequence generation, allocation concealment and
blinding, were not clear.
Stiller 1992 reported that at eight weeks, 1/18 (6%) in the EMT
group and 3/13 people in the sham-EMT group (23%) were lost
to follow up (overall 13%). No ulcers healed in the sham group,
while 50% of ulcers either healed or showedmarked improvement
in the EMT group. This outcome was assessed subjectively and
’marked improvement’ was not a pre-specified outcome, therefore
these data are not included in the analysis. This studywas at unclear
risk of bias overall.
Reduction in wound size
The results from the three studies for the continuous outcome
(reduction in wound size) could not be pooled. No trials reported
any evaluation of the precision of the reduction in wound size
(change from baseline). It was also not possible to derive missing
data from the statistics provided.
Based on complete case analysis in Stiller 1992, the ulcers in the
EMT group were reported to decrease in size by 47% at eight
weeks, whilst in the sham-EMT group the ulcers increased in size
by 49% over the same time period (P value < 0.0002). For the ITT
analysis, thewound area at eightweeks of peoplewho discontinued
the study was determined by two methods: either by estimation
by linear extrapolation to day 56, or by the use of the last observed
wound area in place of the eight-week value. The results based
on the last observed values were reported to be similar to those
based on the extrapolated eight-week values. The EMT group
averaged a 48% decrease in wound surface area compared with a
42% increase seen in the sham-EMT group (P value < 0.0002).
The ulcers appeared evenlymatched for baseline size though ulcers
in the sham group were of longer duration (a prognostic factor for
time to heal).
Time to complete healing
Ieran 1990 reported the mean healing time but did not express the
intervention effect as a hazard ratio which is the most appropriate
way of summarizing time-to-event data. Kenkre 1996 and Stiller
1992 did not report on this outcome.
Secondary outcomes
Cost
Assessment of cost was not undertaken in any of the studies.
Quality of life
Quality of life using a validated scale was not measured in any of
the studies. Kenkre 1996, however, assessed the mobility of par-
ticipants and reported that all groups showed increased mobility
at trial end.
Pain
All the studies reported pain as a secondary outcome; however, the
results of the studies could not be pooled owing to the different
scales used to assess pain. Kenkre 1996 used analogue scales (in
mm) and reported that at the end of the study, significant reduc-
tion in pain scores was only observed for the EMT groups. The
analogue scale used to measure pain in Ieran 1990 was not de-
scribed. At the end of the study, pain was reported to be lower in
both the EMT and sham-EMT groups but the difference between
the groups was not significant. Stiller 1992 reported pain intensity
on a four-point scale where 0 equated to no pain; 1 to mild pain;
2 to moderate pain; and 3 to severe pain. The reduction in pain
score was reported to be significantly more for the EMT group.
Acceptability of treatment
Assessment of acceptability of treatment was not undertaken in
any of the studies.
Adverse effects
Adverse effects were not reported in Ieran 1990 or Stiller 1992.
Kenkre 1996 reported that 13/19 (68%) participants experienced
adverse events. Two participants in the EMT group suffered mod-
erate to severe headaches. Sensations of heat, tingling, and pins and
needles in the limb were experienced by people in both groups.
D I S C U S S I O N
Three small trials involving a total of 94 patients were included in
this review. Whilst one small trial reported significantly more ul-
cers healing with electromagnetic therapy (EMT) compared with
sham-EM, this result was not robust to different assumptions re-
garding the outcomes of patients lost to follow up. One other trial
did not show an effect in favour of EMT while the third trial did
not assess the proportions of ulcers healed.
The extent to which the studies were at risk of bias was variable.
Two of the three studies lacked clarity about the method of allo-
cation concealment; there is evidence that inadequate allocation
concealment leads to an overestimation of the treatment effect
(Schulz 2000). The studies by Kenkre 1996 and Stiller 1992 were
at unclear risk of bias overall with the small study by Ieran 1990
at low to moderate risk of bias.
It is important for trials to use more objective measures of treat-
ment success, such as time to complete healing, when assessing
interventions in wound trials (Grey 2009). Since the assessment
of healing was based on a clinical global assessment in two of the
trials, the blinding of the outcome assessor is critical to ensure de-
tection bias has not been introduced. One study was inadequately
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blinded for investigator-assessed outcomes, even though indistin-
guishable EMT and sham devices were used (Kenkre 1996).
Themethods for handlingmissing data in the trials varied. Kenkre
1996 did not have any drop-outs. Stiller 1992 imputed missing
data using last observation carried forward analysis and estimation
by linear extrapolation for wound area, while Ieran 1990 did not
carry out ITT analysis. We examined whether the results changed
and checked the robustness of the observed findings in Ieran 1990
by performing a worst-case scenario ITT analysis (all the people
who dropped out considered as having wounds not healed) and a
best-case scenario analysis (all the people who dropped out as hav-
ing healed ulcers). The results changed with the two assumptions
made with the assumption (all loss to follow up as having ulcers
healed) showing a significant difference favouring EMT.However,
the worst-case scenario assumption is an extreme and inmost cases
unrealistic assumption (Akl 2009). Nevertheless, our analysis was
valuable in demonstrating that the effect estimate in Ieran 1990
did not remain statistically significant under the assumption of a
worst-case scenario.
Another concern was that two of the studies were sponsored by
the manufacturer of the electromagnetic devices (Kenkre 1996;
Stiller 1992), and whilst there is evidence that industry-sponsored
trials may overestimate the treatment effect (Bhandari 2004), we
were unable to draw any firm conclusions as to whether this has
affected the results of these trials.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
At present, there is no high quality evidence that electromagnetic
therapy (EMT) speeds the healing of venous leg ulcers.
Implications for research
Methodologically sound and robust RCTs are needed in order
to investigate further any effect of using EMT to improve ve-
nous leg ulcer healing.When reporting these trials, authors should
follow the CONSORT statement for reporting controlled trials
(CONSORT 2010) so that the trials can be accurately assessed
by readers and reviewers. In addition, the procedures for diagnos-
ing venous leg ulcers and the stage of the wound(s) should be de-
scribed.
Future studies should explore the effects of EMT as an adjunct to
optimum treatment with compression, and also as an option for
people who cannot tolerate compression or for whom compression
is contraindicated.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ieran 1990
Methods RCT, computer-generated schedule in blocks of 4, double-blind
Participants 44 patients with venous ulcers of at least 3 months’ duration
Baseline data:
Mean duration of ulcer:
EMT group: 30 months (range 3 to 360 months)
Sham-EMT group: 23 months (3 to 240 months)
Ulcers > 15 cm2 (n, mean, SD):
EMT group: 4 (34.2 ± 15.5)
Sham-EMT group: 7 (39.9 ± 23.9)
Ulcers < 15 cm2 (n, mean, SD):
EMT group: 14 (4.8 ± 2.9)
Sham-EMT group: 12 (5.0 ± 3.3)
Interventions EMT group: (n = 22) stimulation of ulcer with single-pulse electric current generating
a magnetic field of 2.8 mT, frequency 75 Hz, impulse width 1.3 ms for 3 to 4 h daily
for maximum of 90 days, or until ulcer healed
Sham-EMT group: (n = 22) sham-EMT with the same duration of treatment as the
EMT group above. Patients did not receive compression therapy during the study
Outcomes Pre-specified outcomes: proportion of complete healing, change in wound area
PRIMARY OUTCOMES
A. Proportion healed at 90 days (excluding loss to follow up):
EMT group: 12/18 (67%)
Sham-EMT group: 6/19 (32%)
P value < 0.02
B. Reduction in wound size at 90 days (excluding loss to follow up):
EMT group: 47% decreased
Sham-EMT group: 30% decreased
C. Time to healing (mean):
EMT group: 76 days
Sham-EMT group: 71 days
SECONDARY OUTCOMES
Pain: reported to be significant at trial end for both groups. However, the difference
between the 2 groups was not significant.
Adverse effects: not reported
Notes Stopped use of stimulator by 3 weeks:
EMT group: 1
Sham-EMT group: 2
Patient used stimulation discontinuously:
EMT group: 1
Sham-EMT group: 1
Allergic reaction to drugs:
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Ieran 1990 (Continued)
EMT group: 1
Sham-EMT group: 0
Developed rheumatoid arthritis:
EMT group: 1
Sham-EMT group: 0
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”patients were randomly dis-
tributed to a control group or experimental
group according to a computer generated
schedule prepared by a biostatistician“
Allocation concealment (selection bias) Low risk Quote: ”the computer generated a list that
assigned equal number of active and con-
trol stimulators in blocks of four, two active
and two dummy units“
“Nobody involved in the study was aware
of the experimental condition; codes used
to include patients in the control and active
groups were opened at the end, when all
evaluation had been completed”
Blinding (performance bias and detection
bias)
wound healed
Low risk Quote: “Nobody involved in the study
was aware of the experimental conditions;
codes used to include patients in the con-
trol or active group were opened at the end,
when all evaluation had been completed.”
“Active and dummy stimulators were ab-
solutely indistinguishable from the outside
both for their shape and for their weight.”
Blinding (performance bias and detection
bias)
wound area
Low risk Quote: “Nobody involved in the study
was aware of the experimental conditions;
codes used to include patients in the con-
trol or active group were opened at the end,
when all evaluation had been completed.”
“Active and dummy stimulators were ab-
solutely indistinguishable from the outside
both for their shape and for their weight”
“The pictures taken on each visit were
shown to 3 different physicians unaware of
the experimental conditions”
Incomplete outcome data (attrition bias)
wound healed
Unclear risk Randomisation: EMT (22); sham-EMT
(22)
At Day 90: EMT (18); sham-EMT (19)
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Ieran 1990 (Continued)
Comment: missing outcome data slightly
more in the EMT group (4/22; 18%) com-
pared to sham-EMT(3/22; 14%)with sim-
ilar reasons for missing data. Bias due to
this slight imbalance was unclear
Incomplete outcome data (attrition bias)
wound area
Unclear risk Comment: missing outcome data slightly
more in the EMT group (4/22; 18%) com-
pared to sham-EMT(3/22; 14%)with sim-
ilar reasons for missing data. Bias due to
this slight imbalance was unclear
Incomplete outcome data (attrition bias)
time to healing
Unclear risk Comment: missing outcome data slightly
more in the EMT group (4/22; 18%) com-
pared to sham-EMT(3/22; 14%)with sim-
ilar reasons for missing data. Bias due to
this slight imbalances was unclear
Selective reporting (reporting bias) Low risk Comment: Pre-specified outcomes were re-
ported
Kenkre 1996
Methods RCT, allocation by pre-determined codes. Pilot study.
Participants 19 patients with venous leg ulcer, with unsatisfactory healing in last 4 weeks
Baseline data:
Mean duration of ulcer:
EMT group A: 230.4 weeks (range 36 to 728 weeks)
EMT group B: 418 weeks (36 to 1368 weeks)
Sham-EMT group: 962.6 weeks (160 to 2548 weeks)
Mean length of ulcer:
EMT group A: 26.6 mm (range 11 to 75 mm)
EMT group B: 49 mm (35 to 74 mm)
Sham-EMT group: 49.1 mm (26 to 115 mm)
Mean ulcer area (measured by weight of sterile acetate sheets covering the wound sites):
EMT group A: 63 mg (range 6 to 269 mg)
EMT group B: 81 mg (46 to 197 mg)
Sham-EMT group: 119 mg (35 to 526 mg)
Patients with repeated ulceration:
EMT group A: 4
EMT group B: 3
Sham-EMT group: 8
Interventions EMT group A: (n = 5) 600Hz electric field, 25 mTmagnetic field, delivered by Elmedis-
traal
EMT group B: (n = 5) 600 Hz on days 1 to 5, 800 Hz on days 6 to 30, 25 mT magnetic
field, delivered by Elmedistraal, 30-min treatment, 5 days a week for 30 days followed
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Kenkre 1996 (Continued)
by 4 weeks’ observation
Sham-EMT group: (n = 9) sham therapy
All patients had ulcer dressings changed by community staff. No standardisation of
dressings. All patients reported to be receiving compression therapy - authors reported
that only 2 patients received ”adequate“ compression
Outcomes Pre-specified outcomes: ulcer area, photograph of the leg, appearance of the ulcer and
surrounding skin, pain intensity and clinical global assessment
PRIMARY OUTCOMES
A. No. of ulcers healed at day 50:
EMT group A: 1/5
EMT group B: 1/5
Sham-EMT group: 2/9
B.Mean ulcer size (range) at day 50: (measured byweight of sterile acetate sheets covering
the wound sites):
EMT group A: 103 mg (0 to 394 mg)
EMT group B: 30 mg (0 to 100 mg)
Sham-EMT group: 78 mg (0 to 373 mg)
C. Time to healing (mean):
This outcome was not assessed
SECONDARY OUTCOMES
Pain [reduction of scores from analogue scales in mm (%)]:
EMT group A: 43 (72%)
EMT group B: 26 (42%)
Sham-EMT group: 6 (not significant)
Adverse effects:
EMT group A: 4
EMT group B: 5
Sham-EMT group: 4
Notes All patients had ulcer dressings changed by community staff. No standardisation of
dressings. All patients reported to be receiving compression therapy - authors reported
only 2 patients received ”adequate“ compression
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: process of randomisation was
not described
Allocation concealment (selection bias) Unclear risk Comment:methodof concealmentwas not
described
Blinding (performance bias and detection
bias)
wound healed
Unclear risk Quote: ”...were randomised to treatment
by either an active or an indistinguishable
placebo machine”
Comment: method of blinding the out-
come assessor was not described, even
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Kenkre 1996 (Continued)
though an indistinguishable device was
used
Blinding (performance bias and detection
bias)
wound area
Unclear risk Comment: method of blinding the out-
come assessor was not described, even
though an indistinguishable device was
used
Incomplete outcome data (attrition bias)
wound healed
Low risk Comment: from the result presented, it was
noted that there were no drop-outs
Incomplete outcome data (attrition bias)
wound area
Low risk Comment: from the result presented, it was
noted that there were no drop-outs
Incomplete outcome data (attrition bias)
time to healing
Unclear risk Comment: from the result presented, it was
noted that there were no drop-outs
Selective reporting (reporting bias) Low risk Comment: Pre-specified outcomes were re-
ported
Other bias Unclear risk Comments: proportion of healed ulcer was
based on clinical global assessment which
was not a validated assessment. There was
probably a risk of bias in the assessment.
Insufficient information to permit judge-
ment for the role played by the sponsor
Stiller 1992
Methods RCT, computer-generated randomisation based on order of admittance to study
Participants 31 patients with venous leg ulcer. Venous leg ulcer < 7.0 cm diameter; no response to
non-surgical treatment in 4 weeks prior to study; ulcer stability (not more than 15%
change in diameter, and not more than 15% change in percentage of granulation tissue,
in 2 weeks prior to study)
Baseline data:
Mean ulcer duration [weeks (SD)]:
EMT group: 38.9 (5.2)
Sham-EMT group: 46.8 (11.3)
Mean ulcer area [cm2 (SD)]:
EMT group: 7.25 (1.02)
Sham-EMT group: 7.66 (1.62)
Mean ulcer depth in cm (SD):
EMT group: 0.24 (0.04)
Sham-EMT group: 0.26 (0.01)
Interventions EMT group: (n = 18) pulsed electromagnetic limb ulcer therapy (PELUT) signal - 3
part pulse 3.5 ms total width, duty cycle of 25%, 0.06 mV/cm, polarity (+, -, +), 3 h
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Stiller 1992 (Continued)
daily for 8 weeks or until the ulcer healed, plus ancillary topical treatment as described
below
Sham-EMT group: (n = 13) placebo device same duration as above plus ancillary topical
treatment
All patients received ancillary topical treatment: compression bandage (20 mmHg at
ankle level) + leg elevation + dressing
Outcomes Pre-specified outcomes: wound surface area, wound depth, granulation tissue, clinical
global assessment, pain intensity
PRIMARY OUTCOMES
A. Number of ulcers healed at 8 weeks:
This outcome was not assessed
B. (i) Percentage change in ulcer size at 8 weeks (complete case analysis):
EMT group: 47% decrease
Sham-EMT group: 49% increase
P value < 0.0002
B (ii) Percentage change in ulcer size at 8 weeks (ITT analysis)
EMT group: 48% decrease
Sham-EMT group: 42% increase
P value < 0.0002
C. Time to healing:
This outcome was not assessed
SECONDARY OUTCOMES
Pain (reduction in intensity at the wound site on a 4-point scale):
EMT group: 0.61
Sham-EMT group: 0.15
(P < 0.04)
Adverse effects: none reported during the study.
Notes Withdrawals:
EMT group: 1
Sham-EMT group: 3
One could not be contacted; 3 others cited personal reasons not related to adverse events
or lack of improvement
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Protocol-eligible patients were
randomized according to a computer-gen-
erated code based on their order of admit-
tance to the study”
Allocation concealment (selection bias) Unclear risk Comment: method of concealment was
not described, but each patient was as-
signed either an active or an indistinguish-
able placebo device according to the code
devised by the study sponsor
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Stiller 1992 (Continued)
Blinding (performance bias and detection
bias)
wound healed
Low risk Quote: ”Each patientwas assigned either an
active or indistinguishable placebo device
according to the code devised by the study
sponsor”.
“All PELUT devices operated silently with
no perceivable thermal, tactile or vibratory
sensation. Neither patients nor investiga-
tors were able to discern any difference be-
tween active and placebo devices.”
Blinding (performance bias and detection
bias)
wound area
Low risk Quote: “...surface area was calculated using
computer image analysis.”
Incomplete outcome data (attrition bias)
wound healed
Unclear risk Comment: missing data in both groups
Incomplete outcome data (attrition bias)
wound area
Low risk Comment: missing data have been im-
puted by 2 appropriate methods. The im-
putation results based on the 2methods are
in agreement
Incomplete outcome data (attrition bias)
time to healing
Unclear risk Comment: this outcome was not assessed
Selective reporting (reporting bias) Low risk Comment: All the specified outcomes in
the method section were reported
Other bias Unclear risk Comment: Insufficient information to per-
mit judgement on the role played by the
sponsor
Abbreviations
< = less than
EMT = electromagnetic therapy
h = hour(s)
Hz = Hertz (unit of frequency)
ITT = intention-to-treat (analysis)
mg = milligram
min = minutes
ms = millisecond
mT= milli Tessla (Tesla = SI unit of magnetic flux density)
n = number in sample group
RCT = randomised controlled trial
SD = standard deviation
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Jeran 1987 Examination of the full-text paper revealed that the study was a controlled clinical trial (CCT) and not a randomised
controlled trial (RCT)
Todd 1991 Examination of the full-text paper revealed that the study was a controlled clinical trial (CCT) and not a randomised
controlled trial (RCT)
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D A T A A N D A N A L Y S E S
Comparison 1. Electromagnetic therapy versus sham therapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Ulcers healed at 90 days
(complete case analysis)
1 37 Risk Ratio (M-H, Fixed, 95% CI) 2.11 [1.01, 4.42]
Comparison 2. Electromagnetic therapy versus sham therapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Ulcers healed at 90 days (per
ITT analysis: withdrawals
considered as ulcers not healed)
1 44 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.92, 4.37]
Comparison 3. Electromagnetic therapy versus sham therapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Ulcers healed at 90 days (per
ITT analysis: withdrawal
considered as ulcers healed)
1 44 Risk Ratio (M-H, Fixed, 95% CI) 1.78 [1.01, 3.12]
Comparison 4. Electromagnetic therapy versus sham therapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Ulcers healed at 50 days (ITT
analysis)
1 19 Risk Ratio (M-H, Fixed, 95% CI) 0.9 [0.16, 5.13]
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Analysis 1.1. Comparison 1 Electromagnetic therapy versus sham therapy, Outcome 1 Ulcers healed at 90
days (complete case analysis).
Review: Electromagnetic therapy for treating venous leg ulcers
Comparison: 1 Electromagnetic therapy versus sham therapy
Outcome: 1 Ulcers healed at 90 days (complete case analysis)
Study or subgroup EMT Sham-EMT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ieran 1990 12/18 6/19 100.0 % 2.11 [ 1.01, 4.42 ]
Total (95% CI) 18 19 100.0 % 2.11 [ 1.01, 4.42 ]
Total events: 12 (EMT), 6 (Sham-EMT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.98 (P = 0.047)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours Sham-EMT Favours Sham
Analysis 2.1. Comparison 2 Electromagnetic therapy versus sham therapy, Outcome 1 Ulcers healed at 90
days (per ITT analysis: withdrawals considered as ulcers not healed).
Review: Electromagnetic therapy for treating venous leg ulcers
Comparison: 2 Electromagnetic therapy versus sham therapy
Outcome: 1 Ulcers healed at 90 days (per ITT analysis: withdrawals considered as ulcers not healed)
Study or subgroup EMT Sham-EMT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ieran 1990 12/22 6/22 100.0 % 2.00 [ 0.92, 4.37 ]
Total (95% CI) 22 22 100.0 % 2.00 [ 0.92, 4.37 ]
Total events: 12 (EMT), 6 (Sham-EMT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.74 (P = 0.082)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours Sham-EMT Favours EMT
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Analysis 3.1. Comparison 3 Electromagnetic therapy versus sham therapy, Outcome 1 Ulcers healed at 90
days (per ITT analysis: withdrawal considered as ulcers healed).
Review: Electromagnetic therapy for treating venous leg ulcers
Comparison: 3 Electromagnetic therapy versus sham therapy
Outcome: 1 Ulcers healed at 90 days (per ITT analysis: withdrawal considered as ulcers healed)
Study or subgroup EMT Sham-EMT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ieran 1990 16/22 9/22 100.0 % 1.78 [ 1.01, 3.12 ]
Total (95% CI) 22 22 100.0 % 1.78 [ 1.01, 3.12 ]
Total events: 16 (EMT), 9 (Sham-EMT)
Heterogeneity: not applicable
Test for overall effect: Z = 2.00 (P = 0.045)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Sham-EMT Favours EMT
Analysis 4.1. Comparison 4 Electromagnetic therapy versus sham therapy, Outcome 1 Ulcers healed at 50
days (ITT analysis).
Review: Electromagnetic therapy for treating venous leg ulcers
Comparison: 4 Electromagnetic therapy versus sham therapy
Outcome: 1 Ulcers healed at 50 days (ITT analysis)
Study or subgroup EMT Sham-EMT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kenkre 1996 2/10 2/9 100.0 % 0.90 [ 0.16, 5.13 ]
Total (95% CI) 10 9 100.0 % 0.90 [ 0.16, 5.13 ]
Total events: 2 (EMT), 2 (Sham-EMT)
Heterogeneity: not applicable
Test for overall effect: Z = 0.12 (P = 0.91)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours Sham-EMT Favours EMT
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A P P E N D I C E S
Appendix 1. Search methods for second update - 2011
Electronic searches
For this second update, we searched the following electronic databases:
• Cochrane Wounds Group Specialised Register (searched 16 February 2011);
• The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 1);
• Ovid MEDLINE (1950 to February Week 1 2011);
• Ovid MEDLINE (In-Process & Other Non-Indexed Citations February 15, 2011);
• Ovid EMBASE (1980 to 2011 Week 06);
• EBSCO CINAHL (1982 to 11 February 2011)
We used the following search strategy in the Cochrane Central Register of Controlled Trials (CENTRAL):
#1 MeSH descriptor Electromagnetic Phenomena explode all trees
#2 MeSH descriptor Electric Stimulation Therapy explode all trees
#3 (electromagnetic* or electrotherap*):ti,ab,kw
#4 (electric* NEXT current):ti,ab,kw
#5 ((direct or pulsed or alternating) NEXT current):ti,ab,kw
#6 (low NEXT intensity) or (low NEXT frequency):ti,ab,kw
#7 (high NEXT voltage):ti,ab,kw
#8 (“TENS” or “NMES”):ti,ab,kw
#9 (interferential NEXT therap*):ti,ab,kw
#10 (monophasic or galvanic):ti,ab,kw
#11 MeSH descriptor Diathermy explode all trees
#12 MeSH descriptor Microwaves explode all trees
#13 (diatherm* or microwave*):ti,ab,kw
#14 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13)
#15 MeSH descriptor Leg Ulcer explode all trees
#16 (varicose NEXT ulcer*) or (venous NEXT ulcer*) or (leg NEXT ulcer*) or (foot NEXT ulcer*) or (stasis NEXT ulcer*) or ((lower
NEXT extremit*) NEAR/2 ulcer*) or (crural NEXT ulcer*) or “ulcus cruris”:ti,ab,kw
#17 (#15 OR #16)
#18 (#14 AND #17)
The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL can be found in Appendix 2, Appendix 3 and
Appendix 4, respectively.We combined the OvidMEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying
randomised trials in MEDLINE: sensitivity- and precision-maximising version (2008 revision) (Lefebvre 2011). We combined the
Ovid EMBASE and EBSCO CINAHL searches with the trial filters developed by the Scottish Intercollegiate Guidelines Network
(SIGN 2009). There were no restrictions on the basis of date or language of publication.
Searching other resources
For this second update, we checked the bibliography of the systematic review by McGaughey 2009.
24Electromagnetic therapy for treating venous leg ulcers (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 2. Ovid MEDLINE search strategy
1 exp Electromagnetic Phenomena/
2 exp Electric Stimulation Therapy/
3 (electromagnetic* or electrotherap*).ti,ab.
4 (electric* adj stimulation).ti,ab.
5 (electric* adj current).ti,ab.
6 ((direct or pulsed or alternating) adj current).ti,ab.
7 (low intensity or low frequency).ti,ab.
8 high voltage.ti,ab.
9 (TENS or NMES).ti,ab.
10 interferential therap*.ti,ab.
11 (monophasic or galvanic).ti,ab.
12 exp Diathermy/
13 exp Microwaves/
14 (diatherm* or microwave*).ti,ab.
15 or/1-14
16 exp Leg Ulcer/
17 (varicose ulcer* or venous ulcer* or leg ulcer* or foot ulcer* or (feet adj ulcer*) or stasis ulcer* or (lower extremit* adj ulcer*) or
crural ulcer* or ulcus cruris).ti,ab.
18 or/16-17
19 15 and 18
Appendix 3. Ovid EMBASE search strategy
1 exp Electromagnetic Field/
2 exp Electrostimulation Therapy/
3 (electromagnetic$ or electrotherap$).ti,ab.
4 (electric$ adj stimulation).ti,ab.
5 (electric$ adj current).ti,ab. (1408)
6 ((direct or pulsed or alternating) adj current).ti,ab.
7 (low intensity or low frequency).ti,ab.
8 high voltage.ti,ab.
9 (TENS or NMES).ti,ab.
10 interferential therap$.ti,ab.
11 (monophasic or galvanic).ti,ab.
12 exp Diathermy/
13 exp Microwaves/
14 (diathermy or microwave$).ti,ab.
15 or/1-14
16 exp Leg Ulcer/
17 (varicose ulcer* or venous ulcer* or leg ulcer* or foot ulcer* or (feet adj ulcer*) or stasis ulcer* or (lower extremit* adj ulcer*) or
crural ulcer* or ulcus cruris).ti,ab.
18 or/16-17
19 15 and 18
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Appendix 4. EBSCO CINAHL Search strategy
S20 S15 and S19
S19 S16 or S17 or S18
S18 lower extremity N3 ulcer* or AB lower extremity N3 ulcer*
S17 TI (varicose ulcer* or venous ulcer* or leg ulcer* or foot ulcer* or (feet N1 ulcer*) or stasis ulcer* or crural ulcer*) or AB (varicose
ulcer* or venous ulcer* or leg ulcer* or foot ulcer* or (feet N1 ulcer*) or stasis ulcer* or crural ulcer*)
S16 (MH “Leg Ulcer+”)
S15 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14
S14 TI ( diatherm* or microwave* ) or AB ( diatherm* or microwave* )
S13 (MH “Microwaves”)
S12 (MH “Diathermy+”)
S11 TI ( monophasic or galvanic ) or AB ( monophasic or galvanic )
S10 TI interferential therap* or AB interferential therap*
S9 TI ( TENS or NMES ) or AB ( TENS or NMES )
S8 TI high voltage or AB high voltage
S7 TI ( low intensity or low frequency ) or AB ( low intensity or low frequency )
S6 TI ( direct current or pulsed current or alternating current ) or AB ( direct current or pulsed current or alternating current )
S5 TI electric* current or AB electric* current
S4 TI electric* stimulation or AB electric* stimulation
S3 TI ( electromagnetic* or electrotherap* ) or AB ( electromagnetic* or electrotherap* )
S2 (MH “Electric Stimulation+”)
S1 (MH “Electromagnetics+”)
Appendix 5. Risk of bias criteria
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
Insufficient information about the sequence generation process to permit judgement of low or high risk of bias.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.
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High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: using an open random allocation schedule (e.g. a list of randomnumbers); assignment envelopes were usedwithout appropriate
safeguards (e.g. if envelopes were unsealed or non opaque or not sequentially numbered); alternation or rotation; date of birth; case
record number; any other explicitly unconcealed procedure.
Unclear
Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not
described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described,
but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others unlikely to introduce bias.
High risk of bias
Any one of the following.
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
Any one of the following.
• Insufficient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following.
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing
bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a
clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
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High risk of bias
Any one of the following.
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce
clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes enough to induce clinically relevant bias in observed effect size.
• ‘As-treated’ analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Any one of the following.
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated,
no reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Any of the following.
• The study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes that are of interest in the
review have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were pre-specified (convincing text of this nature may be uncommon)
High risk of bias
Any one of the following.
• Not all of the study’s pre-specified primary outcomes have been reported.
• One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that
were not pre-specified.
• One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as
an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
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High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• has been claimed to have been fraudulent; or
• had some other problem.
Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or
• insufficient rationale or evidence that an identified problem will introduce bias.
WH A T ’ S N E W
Last assessed as up-to-date: 11 December 2012.
Date Event Description
3 January 2013 New citation required but conclusions have not changed No new trials identified.
3 January 2013 New search has been performed Third update, new search, references updated.
H I S T O R Y
Protocol first published: Issue 4, 1998
Review first published: Issue 1, 2001
Date Event Description
16 February 2011 New citation required but conclusions have not
changed
Authorship of the review changed.
16 February 2011 New search has been performed Second update: new search, one trial (Jeran 1987)
added to table of Characteristics of excluded studies.
Risk of bias assessment of included trials completed
and the conclusions of the review remain unchanged
7 August 2009 Amended Contact details updated.
5 September 2008 Amended Converted to new review format.
1 January 2006 New citation required but conclusions have not
changed
Substantive amendment. For this first update, new
searches were carried out in October 2005. No new
studies were included. One study was excluded (Todd
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(Continued)
1991). The reviewers’ conclusions remain unchanged.
C O N T R I B U T I O N S O F A U T H O R S
Kate Flemming and Nicky Cullum conducted the original review and commented on the final draft of the updates.
Zoriah Aziz undertook the second and third updates, sifted the search results, undertook the risk of bias assessment and revised the
text.
Contributions of editorial base:
Sally Bell-Syer: co-ordinated the editorial process, advised on methodology, interpretation and content, and edited the updated review.
Ruth Foxlee: designed the search strategy for the updated review, ran the searches, and edited the search methods section for the update.
D E C L A R A T I O N S O F I N T E R E S T
None.
S O U R C E S O F S U P P O R T
Internal sources
• Department of Health Sciences, University of York, UK.
External sources
• NHS Health Technology Assessment Programme, UK.
• General Nursing Council of England and Wales Trust, UK.
• NIHR/Department of Health (England), (Cochrane Wounds Group), UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
For the review update, we added an additional outcome, adverse effects, to Characteristics of included studies. The review authors
judged that collecting data on adverse effects was an acceptable post hoc decision.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Wound Healing; Magnetic Field Therapy [∗methods]; Randomized Controlled Trials as Topic; Varicose Ulcer [∗therapy]
MeSH check words
Humans
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